What is the share price of Lactose (India) Ltd (LACTOSE) today?
The share price of LACTOSE as on 7th August 2026 is ₹102. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Lactose (India) Ltd (LACTOSE) share?
The past returns of Lactose (India) Ltd (LACTOSE) share are- Past 1 week: -3.55%
- Past 1 month: -0.97%
- Past 3 months: -11.69%
- Past 6 months: 0.98%
- Past 1 year: 4.06%
- Past 3 years: 33.77%
- Past 5 years: 152.79%
What are the peers or stocks similar to Lactose (India) Ltd (LACTOSE)?
The peers or stocks similar to Lactose (India) Ltd (LACTOSE) include:What is the market cap of Lactose (India) Ltd (LACTOSE) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Lactose (India) Ltd (LACTOSE) is ₹128.41 Cr as of 7th August 2026.What is the 52 week high and low of Lactose (India) Ltd (LACTOSE) share?
The 52-week high of Lactose (India) Ltd (LACTOSE) is ₹136.70 and the 52-week low is ₹76.01.What is the PE and PB ratio of Lactose (India) Ltd (LACTOSE) stock?
The P/E (price-to-earnings) ratio of Lactose (India) Ltd (LACTOSE) is 21.19. The P/B (price-to-book) ratio is 2.19.Which sector does Lactose (India) Ltd (LACTOSE) belong to?
Lactose (India) Ltd (LACTOSE) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Lactose (India) Ltd (LACTOSE) shares?
You can directly buy Lactose (India) Ltd (LACTOSE) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Lactose (India) Ltd
LACTOSE Share Price
BSE₹102.000.78% (-0.80)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
LACTOSE Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
LACTOSE Performance & Key Metrics
LACTOSE Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 21.12 | 2.19 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 46.67 | 6.04 | 0.50% |
LACTOSE Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
LACTOSE Company Profile
Lactose India Limited is a pharmaceutical company engaged in the business of manufacturing pharmaceutical products. The Company is principally engaged in manufacturing of lactose monohydrate
SUNPHARMA
PE Ratio
40.65
40.65
1Y Return
21.48%
21.48%
Buy Reco %
93.33
93.33
TORNTPHARM
PE Ratio
86.57
86.57
1Y Return
37.57%
37.57%
Buy Reco %
82.14
82.14
CIPLA
PE Ratio
30.48
30.48
1Y Return
1.82%
1.82%
Buy Reco %
62.86
62.86
ZYDUSLIFE
PE Ratio
22.05
22.05
1Y Return
18.09%
18.09%
Buy Reco %
53.57
53.57
LUPIN
PE Ratio
20.26
20.26
1Y Return
21.57%
21.57%
Buy Reco %
54.29
54.29
LACTOSE Forecast
LACTOSE Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
LACTOSE
LACTOSE
Income
Balance Sheet
Cash Flow
Quarterly Normal View
LACTOSE Income Statement
LACTOSE Income Statement
Quarterly Normal View
| Quarter | dec 2023 | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 32.88 | 29.70 | 29.68 | 30.75 | 29.28 | 28.14 | 39.99 | 41.55 | 37.40 | 45.98 | ||||||||||
Operating & Other expenses | 26.87 | 23.28 | 23.89 | 25.43 | 25.75 | 24.36 | 35.11 | 35.92 | 33.70 | 40.74 | ||||||||||
EBITDA | 6.01 | 6.42 | 5.79 | 5.32 | 3.53 | 3.78 | 4.88 | 5.63 | 3.70 | 5.24 | ||||||||||
| Depreciation/Amortization | 1.20 | 1.63 | 1.31 | 1.33 | 1.35 | 1.39 | 1.37 | 1.44 | 1.43 | 1.50 | ||||||||||
| PBIT | 4.81 | 4.79 | 4.48 | 3.99 | 2.18 | 2.39 | 3.51 | 4.19 | 2.27 | 3.74 | ||||||||||
| Interest & Other Items | 1.21 | 1.17 | 1.26 | 1.37 | 1.64 | 1.84 | 1.22 | 1.04 | 1.39 | 1.43 | ||||||||||
| PBT | 3.60 | 3.62 | 3.22 | 2.62 | 0.54 | 0.55 | 2.29 | 3.15 | 0.88 | 2.31 | ||||||||||
| Taxes & Other Items | 0.97 | 1.23 | 0.96 | 0.58 | 0.32 | -0.10 | 0.79 | 0.98 | 0.35 | 0.43 | ||||||||||
| Net Income | 2.63 | 2.39 | 2.26 | 2.04 | 0.22 | 0.65 | 1.50 | 2.17 | 0.53 | 1.88 | ||||||||||
| EPS | 2.09 | 1.91 | 1.80 | 1.61 | 0.17 | 0.51 | 1.19 | 1.71 | 0.42 | 1.49 |
LACTOSE Company Updates
LACTOSE Stock Peers
LACTOSE Past Performance & Peer Comparison
LACTOSE Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Lactose (India) Ltd | 21.19 | 2.19 | — |
| Sun Pharmaceutical Industries Ltd | 40.65 | 5.56 | 0.82% |
| Torrent Pharmaceuticals Ltd | 86.57 | 10.65 | 0.69% |
| Cipla Ltd | 30.48 | 3.43 | 0.89% |
LACTOSE Stock Price Comparison
Compare LACTOSE with any stock or ETFCompare LACTOSE with any stock or ETF
LACTOSE
LACTOSE Holdings
LACTOSE Shareholdings
LACTOSE Promoter Holdings Trend
LACTOSE Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
LACTOSE Institutional Holdings Trend
LACTOSE Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
LACTOSE Shareholding Pattern
LACTOSE Shareholding Pattern
LACTOSE Shareholding History
LACTOSE Shareholding History
Foreign Institutions
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing LACTOSE stock
smallcases containing LACTOSE stock
Looks like this stock is not in any smallcase yet.
LACTOSE Events
LACTOSE Events
LACTOSE Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
LACTOSE has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
LACTOSE Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
LACTOSE has not given any dividends in last 5 years
LACTOSE Dividends
LACTOSE Dividends
Hmm, looks like data is unavailable here. Please come back after some timeLACTOSE Stock News & Opinions
LACTOSE Stock News & Opinions
Articles & Videos
Corporate
Corporate
Lactose (India) Limited to review Q1 financial results at board meeting August 11Lactose (India) Limited will hold a board meeting on Tuesday, August 11, 2026, to consider and approve the unaudited financial results for the first quarter ended June 30, 2026, along with a limited review report from its statutory auditor, according to a regulatory filing with the BSE Limited. The trading window for the company's securities has been closed for directors, officers, and designated employees since July 1, 2026, and will reopen 48 hours after the financial results are declared.
2 days agoCapital Market - Live
Corporate
Corporate
Lactose (India) to hold board meetingLactose (India) will hold a meeting of the Board of Directors of the Company on 18 June 2026.
1 month agoCapital Market - Live
Earnings
Earnings
Lactose (India) standalone net profit rises 193.75% in the March 2026 quarterNet profit of Lactose (India) rose 193.75% to Rs 1.88 crore in the quarter ended March 2026 as against Rs 0.64 crore during the previous quarter ended March 2025. Sales rose 64.82% to Rs 45.77 crore in the quarter ended March 2026 as against Rs 27.77 crore during the previous quarter ended March 2025. For the full year,net profit rose 17.44% to Rs 6.06 crore in the year ended March 2026 as against Rs 5.16 crore during the previous year ended March 2025. Sales rose 40.28% to Rs 163.29 crore in the year ended March 2026 as against Rs 116.40 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales45.7727.77 65 163.29116.40 40 OPM %10.9712.24 -11.2614.57 - PBDT3.811.93 97 14.3612.31 17 PBT2.310.54 328 8.626.92 25 NP1.880.64 194 6.065.16 17 Powered by Capital Market - Live
2 months agoCapital Market - Live
Spotlight
Spotlight
Lactose India spurts after Q4 PAT climbs 194% YoY to Rs 2 crRevenue from operations soared 64.81% year-on-year to Rs 45.77 crore in the quarter ended 31 March 2026. Total expenses increased 58.28% year-on-year to Rs 43.67 crore during the quarter, compared with Rs 27.59 crore in the year-ago period. The cost of materials consumed stood at Rs 28.28 crore, up 59.23% YoY, while employee benefits expenses rose 5.37% to Rs 3.53 crore. Profit before tax (PBT) stood at Rs 2.31 crore in Q4 FY26, registering a growth of 320% from Rs 0.55 crore reported in Q4 FY25. For the full financial year FY26, the company posted a 17.44% rise in consolidated net profit to Rs 6.06 crore, while revenue rose 40.28% to Rs 163.29 crore compared with FY25. Lactose (India) is a pharmaceutical company engaged in the business of manufacturing, trading and carrying out job work and manufacturing of pharmaceutical products. Powered by Capital Market - Live
2 months agoCapital Market - Live
Corporate
Corporate
Lactose (India) declare Quarterly ResultLactose (India) will hold a meeting of the Board of Directors of the Company on 20 May 2026.
2 months agoCapital Market - Live
Corporate
Corporate
Lactose (India) to conduct EGMLactose (India) announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 28 March 2026.Powered by Capital Market - Live
5 months agoCapital Market - Live
Earnings
Earnings
Lactose (India) standalone net profit rises 140.91% in the December 2025 quarterNet profit of Lactose (India) rose 140.91% to Rs 0.53 crore in the quarter ended December 2025 as against Rs 0.22 crore during the previous quarter ended December 2024. Sales rose 28.03% to Rs 36.77 crore in the quarter ended December 2025 as against Rs 28.72 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales36.7728.72 28 OPM %8.3510.34 - PBDT2.311.89 22 PBT0.880.54 63 NP0.530.22 141 Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Corporate
Lactose (India) to declare Quarterly ResultsLactose (India) will hold a meeting of the Board of Directors of the Company on 13 February 2026.Powered by Capital Market - Live
5 months agoCapital Market - Live
Earnings
Earnings
Lactose (India) standalone net profit rises 6.40% in the September 2025 quarterNet profit of Lactose (India) rose 6.40% to Rs 2.16 crore in the quarter ended September 2025 as against Rs 2.03 crore during the previous quarter ended September 2024. Sales rose 35.24% to Rs 41.18 crore in the quarter ended September 2025 as against Rs 30.45 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales41.1830.45 35 OPM %12.7516.45 - PBDT4.583.94 16 PBT3.142.61 20 NP2.162.03 6 Powered by Capital Market - Live
8 months agoCapital Market - Live
Corporate
Corporate
Lactose (India) to announce Quarterly ResultLactose (India) will hold a meeting of the Board of Directors of the Company on 13 November 2025.Powered by Capital Market - Live
9 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 36.04%, vs industry avg of 12.48%
Over the last 5 years, market share increased from 0.01% to 0.03%